Study of 23-valent pneumococcal polysaccharide vaccine and influenza vaccine against pneumococcal pneumonia among elderly patients
Latest Information Update: 12 Nov 2018
At a glance
- Drugs Pneumococcal 23-valent vaccine Walvax Biotechnology (Primary)
- Indications Pneumococcal infections
- Focus Therapeutic Use
- 12 Nov 2018 New trial record
- 07 Oct 2018 Results presented at the IDWeek 2018